Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03481556
Title Study of Melflufen + Dex With Bortezomib or Daratumumab in Patients With RRMM (ANCHOR)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Oncopeptides AB
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP


No variant requirements are available.